Live Breaking News & Updates on Ehave Infinity Portal|Page 5

Stay updated with breaking news from Ehave infinity portal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector


News Category Global Banking & Finance Reviews
Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector
Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector
MIAMI, Jan. 20, 2021 Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics, announced today the Company has closed the transaction to sell 100% of its
Mycotopia Therapy subsidiary to 20/20 Global Inc. (OTC Pink: TWGL). As a result of the transaction closing, Ehave controls approximately 75.77% of the outstanding shares of 20/20 Global. 20/20 Global Inc. plans to file with FINRA to change the name of the company to Mycotopia Therapy. ....

United States , Mark Croskery , Gabe Rodriguez , Ben Kaplan , Global Inc , Electronic Health Records Ehrs , Risk Factors In Ehave Inc , Croskery Capital , Contact For Ehave Inc , Exchange Commission , Ehave Magic Mushroom Company To Enter Jamaica , Additional Ehave Inc , Ehave Inc , Croskery Capital Limited , Jamaica Gleaner , Magic Mushroom Company To Enter Jamaica , Taps Croskery As Director Of Subsidiary , Kaya As Wellness Adviser And , Mycotopia Therapies , Ehave Dashboard , Electronic Health Records , Ehave Telemetry Portal , Ehave Infinity Portal , Mycotopia Therapy , Private Securities Litigation Reform Act , Registration Statement ,

Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value


[December 28, 2020]
Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value
MIAMI, Dec. 28, 2020 (GLOBE NEWSWIRE) Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics and developer of KetaDASH, a home delivery platform for patients who have been prescribed Ketamine infusions, announced today the Company s Board of directors has elected to sell 100% of its Mycotopia Therapies subsidiary to 20/20 Global Inc. (OTC Pink: TWGL) for $350,000 while simultaneously acquiring approximately 75.77% of 20/20 Global’s outstanding shares from 20/20 Global’s management.
20/20 Global currently trades on the OTC under the symbol TWGL and is a reporting issuer with the US Securities and Exchange Commission. The transaction is expected to close January 4, 2021. Ehave Chairman and CEO Ben Kaplan will be named as Chairman and CEO of 20/20 Global, with the current 20/20 Global board stepping down upon completio ....

United States , Mark Croskery , Gabe Rodriguez , Ben Kaplan , Global Inc , Electronic Health Records Ehrs , Risk Factors In Ehave Inc , Croskery Capital , Exchange Commission , Company Board , Additional Ehave Inc , Ehave Inc , Psychedelitech Inc , Announces Repositioning , Mycotopia Therapies , Maximize Shareholder , Central America , Croskery Capital Limited , South America , Ehave Dashboard , Electronic Health Records , Ehave Telemetry Portal , Ehave Infinity Portal , Mycotopia Therapy , Private Securities Litigation Reform Act , Registration Statement ,